0001104659-16-140127.txt : 20160816
0001104659-16-140127.hdr.sgml : 20160816
20160816203151
ACCESSION NUMBER: 0001104659-16-140127
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160812
FILED AS OF DATE: 20160816
DATE AS OF CHANGE: 20160816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZASLOFF MICHAEL A
CENTRAL INDEX KEY: 0001033511
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 161837337
4
1
a4.xml
4
X0306
4
2016-08-12
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001033511
ZASLOFF MICHAEL A
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
0
0
0
Common Stock
2016-08-12
4
M
0
10381
15.23
A
42792
D
Common Stock
2016-08-12
4
M
0
20594
14.23
A
63386
D
Common Stock
2016-08-12
4
S
0
30975
18.1157
D
32411
D
Common Stock
2016-08-15
4
M
0
17400
14.23
A
49811
D
Common Stock
2016-08-15
4
S
0
17400
18.2168
D
32411
D
Stock Option (right to buy)
15.23
2016-08-12
4
M
0
10381
0
D
2016-10-03
Common Stock
10381
0
D
Stock Option (right to buy)
14.23
2016-08-12
4
M
0
20594
0
D
2016-12-10
Common Stock
20594
17400
D
Stock Option (right to buy)
14.23
2016-08-15
4
M
0
17400
0
D
2016-12-10
Common Stock
17400
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.39, inclusive.
Shares subject to the option are fully vested and immediately exercisable.
/s/ Ken Stupak, by power of attorney
2016-08-15